OpenEye Scientific is now part of Cadence

Partnerships and Engagements

OpenEye actively seeks partnerships and engagements with like-minded organizations looking to advance today's molecular-design technologies.

Our partners include:

Specifica - in antibody discovery
Gaussian - in quantum modeling
CCDC - protein-ligand docking with GOLD

Together, we create new methodologies, integrate proprietary methods, secure intellectual property (IP), and more.

To inquire about working with OpenEye on your endeavors, please contact us at info@eyesopen.com.

Specifica Testimonial

Resources

Glimpse the Future through News, Events, Webinars and more

News

ROCS X: AI-Enabled Molecular Search Unlocks Trillions

BOSTON, OpenEye miniCUP—Sept. 25, 2025—Cadence Molecular Sciences (OpenEye), a business unit of Cadence (Nasdaq: CDNS), announced today at miniCUP Boston, the launch of ROCS X, an AI-enabled virtual screening solution that allows scientists to conduct 3D searches of trillions of drug-like molecules.

Webinar

Webinar: Modular Molecular Modeling

Webinar: Modular Molecular Modeling About this session: This webinar will provide an overview of our software libraries or toolkits, with an emphasis on how they can be used to efficiently develop customized, integrated solutions to complex problems in modern drug discovery. We will highlight several examples of the impact our toolkits have in solving a wide variety of problems for our users, including work from PubChem, Pfizer, and AstraZeneca. We will also illustrate the central place that they play in developing our own solutions.

Webinar

Webinar: OpenEye's Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch

Upcoming Webinar

Webinar: Own Your Own Target with Target X

News

Cadence Tool Reveals Druggable Sites with Over 90% Accuracy

cta-bg-desktop

cta-bg-mobile

Get Started

Accelerate your Science with OpenEye

Let’s Connect